Current treatment landscape of HR+/HER2− advanced breast cancer in the Nordics: a modified Delphi study

Author:

Geisler Jürgen1,Karihtala Peeter2,Tuxen Malgorzata3,Valachis Antonis4,Holm Barbro5,Ahlin Cecilia6,Bergquist Fosskaug Cathrine7,Bergqvist Jenny8,Bosch Campos Ana9,Harder Brix Eva10,Jakobsen Erik Hugger11,Jensen Anders Bonde12,Johannsson Oskar13,Jääskeläinen Minna14,Kursetgjerde Torgunn15,Linderholm Barbro16,Lindman Henrik17,Mannsåker Bård18,Narbe Ulrik19,Porojnicu Alina Carmen20,Selander Katri21,Songe-Møller Silje22,Støre Blix Egil23,Knop Ann Søegaard24,Thulin Anna25,Tiainen Leena26,Weder Anna27,Yammeni Sophie28,

Affiliation:

1. Department of Oncology, University of Oslo and Akershus University Hospital, Akershus, Norway

2. Department of Oncology, Helsinki University Hospital Comprehensive Cancer Centre and University of Helsinki, Helsinki, Finland

3. Department of Oncology, University of Copenhagen Herlev Hospital, Copenhagen, Denmark

4. Department of Oncology, Örebro University Hospital, Örebro, Sweden

5. Department of Oncology, Novartis, Stockholm, Sweden

6. Department of Oncology, Karlstad Hospital, Karlstad, Sweden

7. Akershus University Hospital, Akershus, Norway

8. Department of Medical Epidemiology and Biostatistics/Kirurgmottagningen, Karolinska Institutet and Capio St Görans sjukhus, Stockholm, Sweden

9. Department of Hematology, Oncology and Radiotherapy, Lund University Hospital, Lund, Sweden

10. Herlev and Gentofte Hospital, Herlev/Gentofte, Denmark

11. Sygehus Sønderjylland, Sønderborg, Denmark

12. Aarhus University Hospital, Aarhus, Denmark

13. Landspitali Hospital, Reykjavik, Iceland

14. Lapland Central Hospital, Rovaniemi, Finland

15. Møre and Romsdal Hospital, Ålesund, Norway

16. Department of Oncology, Sahlgrenska Academy and University Hospital, Gothenburg, Sweden

17. Department of Immunology, Genetics and Pathology, Experimental and Clinical Oncology and Clinical Oncology, Uppsala University Hospital, Uppsala, Sweden

18. Nordland Hospital, Bodø, Norway

19. Växjö Regional Hospital, Växjö, Sweden

20. Vestre Viken Hospital, Drammen, Norway

21. Oulu University hospital, Oulu, Finland

22. Østfold Hospital, Kalnes, Norway

23. University Hospital of North Norway HF, Tromsø, Norway

24. Rigshospitalet/Copenhagen University Hospital, Copenhagen, Denmark

25. Department of Oncology, Sahlgrenska Academy, Gothenburg, Sweden

26. Tampere University Hospital, Tampere, Finland

27. Mälarsjukhuset Hospital, Eskilstuna, Sweden

28. Aalborg University Hospital, Aalborg, Denmark

Funder

Novartis

Publisher

Medical Journals Sweden AB

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Reference51 articles.

1. NORDCAN. NORDCAN countries excl. Faroe Islands and Greenland – Breast. Lyon (France): NORDCAN; 2021. p. 2.

2. Pooled Analysis of Nine Cohorts Reveals Breast Cancer Risk Factors by Tumor Molecular Subtype

3. US Incidence of Breast Cancer Subtypes Defined by Joint Hormone Receptor and HER2 Status

4. Systemic treatment of hormone receptor positive, human epidermal growth factor 2 negative metastatic breast cancer: retrospective analysis from Leeds Cancer Centre

5. American Cancer Society. Breast cancer hormone receptor status. Atlanta (GA): American Cancer Society; 2021.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3